Ideaya Biosciences (IDYA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec5

IDEAYA Biosciences and Biocytogen Pharmaceuticals Obtain FDA Approval for IDE034 IND Application

00:00

Nov12

Mizuho Raises IDEAYA Biosciences Price Target to $46

14:29

Nov10

Mizuho Securities and RBC Capital Reiterate Buy Rating on IDEAYA Biosciences

14:12

Nov5

Ideaya Biosciences released FY2025 9 Months earnings on November 4, 2025 (EST), actual revenue USD 207.83 M, actual EPS USD -0.3627

04:00

Ideaya Biosciences released FY2025 Q3 earnings on November 4, 2025 (EST), actual revenue USD 207.83 M (forecast USD 59.98 M), actual EPS USD 1.33 (forecast USD -0.3906)

04:00

Nov4

IDEAYA Biosciences Announces Q3 2025 Financial Results

11:10

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 207.83 M, Net Income 119.24 M, EPS 1.33

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -77.49 M, EPS -0.8758

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -72.18 M, EPS -0.8168

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change